Abstract:Cytochrome P450 3A4 (CYP3A4), a key enzyme, is pivotal in metabolizing approximately half of the drugs used clinically. The genetic polymorphism of the CYP3A4 gene significantly influences individual variations in drug metabolism, potentially leading to severe adverse drug reactions (ADRs). In this study, we conducted a genetic analysis on CYP3A4 gene in 1163 Chinese Han individuals to identify the genetic variations that might affect their drug metabolism capabilities. For this purpose, a multiplex polymerase chain reaction (PCR) amplicon sequencing technique was developed, enabling us to perform the genotyping of CYP3A4 gene efficiently and economically on a large scale. As a result, a total of 14 CYP3A4 allelic variants were identified, comprising six previously reported alleles and eight new nonsynonymous variants that were nominated as new allelic variants *39–*46 by the PharmVar Association. Further, functional assessments of these novel CYP3A4 variants were undertaken by coexpressing them with cytochromes P450 oxidoreductase (CYPOR) in Saccharomyces cerevisiae microsomes. Immunoblot analysis indicated that with the exception of CYP3A4.40 and CYP3A4.45, the protein expression levels of most new variants were similar to that of the wild-type CYP3A4.1 in yeast cells. To evaluate their catalytic activities, midazolam was used as a probe drug. The results showed that variant CYP3A4.45 had almost no catalytic activity, whereas the other variants exhibited significantly reduced drug metabolism abilities. This suggests that the majority of the CYP3A4 variants identified in the Chinese population possess markedly altered capacities for drug metabolism. SIGNIFICANCE STATEMENT In this study, we established a multiplex polymerase chain reaction (PCR) amplicon sequencing method and detected the maximum number of new CYP3A4 variants in a single ethnic population. Additionally, we performed the functional characterizations of these eight novel CYP3A4 allele variants in vitro. This study not only contributes to the understanding of CYP3A4 genetic polymorphism in the Chinese Han population but also holds substantial reference value for their potential clinical applications in personalized medicine.

Analysis of CYP2J2 polymorphisms in the Chinese Uyghur population

Analysis of <i>CYP2J2</i> mutations in the Chinese Uyghur population

Identification and Functional Assessment of EightCYP3A4Allelic Variants39–46Detected in the Chinese Han Population

Genetic polymorphism analysis of the drug-metabolizing enzyme CYP1A2 in a Uyghur Chinese population: a pilot study.

Polymorphisms of Drug-Metabolizing Enzyme CYP2E1 in Chinese Uygur Population

Genetic polymorphisms of the drug-metabolizing enzyme CYP2C19 in the Uyghur population in northwest China.

Genetic Polymorphisms of the Drug-Metabolizing Enzyme Cytochrome P450 3a5 in A Uyghur Chinese Population

Identification of Genetic Polymorphisms of CYP2W1 in the Three Main Chinese Ethnicities: Han, Tibetan, and Uighur.

Polymorphisms and Phenotypic Analysis of Cytochrome P450 3A4 in the Uygur Population in Northwest China.

Genetic polymorphisms of CYP2S1, CYP2J2 and CYP2R1 genes in three Chinese populations: Han, Tibetan and Uighur.

Novel Single Nucleotide Polymorphisms (snps) of CYP2W1 Gene in Chinese Uygur and Han Populations

Genetic Polymorphism Analysis of Cytochrome P4502E1 (CYP2E1) in a Chinese Tibetan Population.

Genotype-Phenotype Analysis of Cyp2c19 in the Tibetan Population and Its Potential Clinical Implications in Drug Therapy

Genetic Polymorphism Analysis of the Drug-Metabolizing Enzyme CYP2C9 in a Chinese Tibetan Population.

Polymorphisms of drug-metabolizing enzyme CYP 2 J 2 in Wa population from Yunnan Province of China

Genetic Polymorphisms of the Drug-Metabolizing Enzyme CYP2J2 in a Tibetan Population

Genetic Polymorphisms Of The Drug-Metabolizing Enzyme Cytochrome P450 2a6 In A Tibetan Chinese Population

Genetic Polymorphisms And In Silico Mutagenesis Analyses Of Cyp2c9, Cyp2d6, And Cypor Genes In The Pakistani Population

Polymorphisms and phenotypic analysis of cytochrome P450 2D6 in the Tibetan population.

Genetic Polymorphisms and Phenotypic Analysis of Drug-Metabolizing Enzyme CYP2C19 in a Li Chinese Population.

Characterization of 15 CYP2J2 variants identified in the Chinese Han population on the metabolism of ebastine and terfenadine in vitro